| Code | 42171 | ||||||||||
| MA number | 59/0294/04-S | ||||||||||
| Product Form: | tbl 250x0,25 mg (blis.Al/PA/Al/PVC) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Novartis Slovakia s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PA/Al/PVC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 16.12.2004 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Certican_ 0,25 mg_0,75 mg_tbl_09.2024.pdf
|
| PIL: |
PIL_Certican_tbl_09.2025.pdf
|
| Safety feature | Yes |
| Data update: | 12.09.2024 |
